Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new BBC Radio 4 series: The Anatomy of Melancholy will air from Monday 11 May at 1.45 pm. The first episode is entitled - Who is free from melancholy?

In 1621, Robert Burton published The Anatomy of Melancholy. It was the first attempt in the modern western world to understand and categorise causes, symptoms and treatments of that universal human experience.

Writing from Oxford where he was a life-long scholar, librarian of Christ Church and a vicar, Burton drew on the writing of others and also his own experiences.

Four hundred years on, when clinical depression is stated to be the leading cause of global disability, and there are many challenges to our mental health, a new series for BBC Radio 4 is asking: how far have we come? And is there anything we can learn from Burton’s Anatomy of Melancholy to help us today?

This new BBC Radio 4 series will run across two weeks from Monday 11 May, Mon-Fri, 1.45 pm, with an omnibus edition on Friday evenings.

Simon Russell Beale will read sections of The Anatomy throughout.

Professor John Geddes, Head of Department, will feature in episodes 1, 2 and 10. He has also been a series consultant.

Read more on the Department of Psychiatry website

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.